1 / 38

Updates in HIV

Updates in HIV. Simha Reddy HMC Noon Conference June 6, 2012. LEARNING. Change Behavior. Topics. Testing Treatment Prevention Being smart about STDs. Testing. Testing.

Download Presentation

Updates in HIV

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Updates in HIV Simha Reddy HMC Noon Conference June 6, 2012

  2. LEARNING

  3. Change Behavior

  4. Topics • Testing • Treatment • Prevention • Being smart about STDs

  5. Testing

  6. Testing • Male pt turned 50 yesterday and here for a routine physical. No medical problems and no health complaints. No notable family history or bad habits. Eats well and exercises regularly. Exam is benign. What’s your next step? • “Happy Birthday! I got you a colonoscopy! • “Well, you don’t looklike you have colon cancer. I’ll see you in a couple years.”

  7. Current HIV Screening Guidelines • 2006 CDC Guidelines • Unless prevalence is less than 1/1000, routine screening of all persons aged 13-64 in all health care settings • Screen again with STD screens, before TB therapy, before new relationship, if > 1 partner since last test, or on clinical judgment • Annually for high risk: IVDU, sex workers, partners of above or of HIV+ ? Did you know? All baby boomers (born 1945 – 1965) should be screened for Hepatitis C. (draft CDC recommendation on May 18,2012)

  8. Testing • How would you provide HIV screening for that same 50 yo asymptomatic patient? • HIV antibody (EIA or enzyme immunoassay) • HIV RNA PCR • Western blot • HIV RNA PCR and antibody (EIA) Did you know? 17% of all HIV positive patients are over the age of 50 Curr. Infect. Dis. Reports 2009, 11:246-254

  9. Testing • 29 yo MSM comes to clinic with several days of sore throat and fever. Had unprotected receptive anal sex two weeks ago. • HIV antibody (EIA) • HIV RNA PCR • Western blot • HIV RNA PCR and antibody (EIA) Did you know? Mono is “glandular fever” in England. In a recent study, 11 of 857 with mono-like sx had acute HIV. Only 3 caught on presentation. HIV Medicine, 2012 (online: doi: 10.1111/j.1468-1293.2012.01023.x)

  10. Window period

  11. To Review • Everyone should be tested • HIV ab for screening (serum, rapid swab) • If concerned about acute HIV: • HIV RNA + antibody • Repeat antibody testing in 3 months Coming soon $34.95

  12. Treatment

  13. Treatment • 28 yohealthy W comes to clinic with a new dx of HIV after routine testing. Last negative HIV test in 2010. CD4 of 740 and viral load of 6800. Your advice? • Begin HAART now • Wait until CD4 < 500 • Wait until CD4 < 350 • Wait until CD4 < 200

  14. 2012 HHS Guidelines

  15. Wait Treat Everyone History of ARV initiation

  16. \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ Viral load 500 350 200 or 14% (AIDS) CD4 count

  17. PJP Crypto Toxo KS Etc. HIV \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \

  18. NA-ACCORD Kitahata et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. NEJM, 2009; 360 (18): 1815-1826

  19. So what are her options? • NRTI backbone emtricitabine/tenofovir = Truvada • Atripla = efavirenz (NNRTI) + Truvada • atazanavir(PI) + ritonavir (PI) + Truvada • darunavir(PI) + ritonavir (PI)+ Truvada • raltegravir(integrase inhibitor) + Truvada Did you know? Ritonavir used to decrease metabolism of other PI (boosting)

  20. BID Atripla Pros - convenience Cons - CNS effects - teratogenic Atazanvir-r Pros - high barrier to resistance Cons - GI side effects - lipids - needs low pH - interactions (statins, rifampin fluticasone. . .) Darunavir-r Pros - high barrier to resistance Cons - GI side effects - lipids - interactions Raltegravir Pros - few side effects Cons - BID dosing - elevated CK

  21. On the horizon • Complera • (rilpivirine/tenofovir/emtricitabine) • already here! • few CNS effects • caution if viral peak > 100,000 • Quad pill • (elvitegravir/tenofovir/emtricitabine/cobicistat) • Fewer side effects. Cobicistat is a booster.

  22. Review • TREAT EVERYONE (think about adherence) • Chronic illness is exacerbated • Decide based on side effect profile • It will only get easier

  23. Prevention

  24. PrEP • Pre-exposure prophylaxis • Truvada, the OTHER “little blue pill”

  25. PrEP • iPrEX • Multinational RCT with ~2500 men who have sex with men • Relative risk reduction of 44% with Truvada • NNT of 89, most of those infected in intervention were not actually taking the drug • Partners PrEP • 4758 serodiscordant heterosexual couples • Infected: 17 w/ TDF, 13 w/ FTC/TDF, 52 in control • RRR of 65 to 75%

  26. Barriers to PrEP • Adherence • Resistance • Cost

  27. Who is PrEP for? • CDC preliminary guidance • can be considered in high risk MSM patients • Need q3month HIV/STD testing • FDA committee • MSM • Serodiscordant • At risk due to sexual activity • STAY TUNED . . . final decision TOMORROW

  28. Better news. . .txprevents spread • HPTN (HIV Prevention Trials Network) 052 • Multinational RCT • 1763 serodiscordant couples (97% heterosexual) • Control treated with HAART once <250 or AIDS • Experimental treated right away • 96% reduction in infection rate • Of 28 infections traced to partner, only one in treatment arm • Stopped early by DSMB last year

  29. Review • PrEP can be considered in high risk MSM and serodiscordant couples. Find out more tomorrow • Better strategy: treat the people with HIV

  30. STD TESTING UPDATE

  31. STD Testing • 19 yo asymptomatic woman gets routine STD testing. Because you remembered to ask about anal sex, you got a rectal swab in addition to urine. NAAT has returned positive for gonorrhea, but not chlamydia. What is the best choice? • Cefixime 400 PO • Cefixime 400 PO + Azithromycin 1 gram PO • Ceftriaxone 250 IM • Ceftriaxone 250 IM + Azithromycin 1 gram PO

  32. Gonorrhea resistance historically • sulfonamides • penicillin • tetracycline • ciprofloxacin • cephalosporins? • azithromycin?

  33. Syphilis • The old way to screen or test RPR

  34. Syphilis • The new, “improved” way Treponemal specific EIA TP-PA (treponemal) No syphilis RPR No syphilis syphilis still syphilis (late latent or treated)

  35. REVIEW • Gonorrhea is smarter than you • Ceftriaxone IM + azithromycin (even if chlamydia negative) • Careful, syphilis testing is now annoying • Order a quant RPR if your pt has had syphilis • STD clinic is amazing. AMAZING. Call them about your pt

  36. CONCLUSION • TEST EVERYONE • TREAT EVERYONE • Watch the news for PrEP • Ceftriaxone + azithro for gonorrhea • Think about quantitative RPRs

  37. QUESTIONS

More Related